Abstract:Abstract Background Oridonin, a tetracycline diterpenoid compound, has the potential antitumor activities. Here, we evaluate the antitumor activity and action mechanisms of oridonin in colorectal cancer. Methods Effects of oridonin on cell proliferation were determined by using a CCK-8 Kit. Cell cycle distribution was determined by flow cytometry. Apoptosis was examined by analyzing subdiploid population and terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling assay. Senescent cells were determined by senescence-associated β-galactosidase activity analysis. Semi-quantitative RT-PCR was used to examine the changes of mRNA of p16, p21, p27 and c-myc. The concomitant changes of protein expression were analyzed with Western blot. Expression of AcH3 and AcH4 were examined by immunofluorescence staining and Western blots. Effects of oridonin on colony formation of SW1116 were examined by Soft Agar assay. The in vivo efficacy of oridonin was detected using a xenograft colorectal cancer model in nude mice. Results Oridonin induced potent growth inhibition, cell cycle arrest, apoptosis, senescence and colony-forming inhibition in three colorectal cancer cell lines in a dose-dependent manner in vitro. Daily i.p. injection of oridonin (6.25, 12.5 or 25 mg/kg) for 28 days significantly inhibited the growth of SW1116 s.c. xenografts in BABL/C nude mice. With western blot and reverse transcription-PCR, we further showed that the antitumor activities of oridonin correlated with induction of histone (H3 and H4) hyperacetylation, activation of p21, p27 and p16, and suppression of c-myc expression. Conclusion Oridonin possesses potent in vitro and in vivo anti-colorectal cancer activities that correlated with induction of histone hyperacetylation and regulation of pathways critical for maintaining growth inhibition and cell cycle arrest. Therefore, oridonin may represent a novel therapeutic option in colorectal cancer treatment.

In Vitro and in Vivo Antitumor Activity of Oridonin Nanosuspension

Oridonin Nanosuspension Enhances Anti-Tumor Efficacy in SMMC-7721 Cells and H22 Tumor Bearing Mice

Oridonin Inhibits Bxpc-3 Cell Growth Through Cell Apoptosis

Oridonin Nanosuspension Was More Effective Than Free Oridonin on G2/M Cell Cycle Arrest and Apoptosis in the Human Pancreatic Cancer PANC-1 Cell Line.

Oridonin-Loaded Nanoparticles Inhibit Breast Cancer Progression Through Regulation of ROS-Related Nrf2 Signaling Pathway

Growth Inhibition and Induction of Apoptosis in Mcf-7 Breast Cancer Cells by Oridonin Nanosuspension

Antitumor Effect of Chinese Herb Oridonin on Human Non-Small Cell Lung Cancer (Nsclc).

Oridonin induces apoptosis and senescence of colorectal cancer SW1116 cells in vitro and in vivo

Preparation of Oridonin Nanocrystals and Study of Their Endocytosis and Transcytosis Behaviours on MDCK Polarized Epithelial Cells.

Oridonin Inhibits the Proliferation, Migration and Invasion of Human Osteosarcoma Cells Via Suppression of Matrix Metalloproteinase Expression and STAT3 Signalling Pathway.

Figure S6 from Targeting AKT with Oridonin Inhibits Growth of Esophageal Squamous Cell Carcinoma <i>in Vitro</i> and Patient-Derived Xenografts <i>in Vivo</i>

Effects of Oridonin on Proliferation of HT29 Human Colon Carcinoma Cell Lines Both in Vitro and in Vivo in Mice.

Preparation of nano-crystalline of oridonin and its effect on cell proliferation and apoptosis of colorectal cancer cells in vitro

Oridonin induces apoptosis and senescence in colorectal cancer cells by increasing histone hyperacetylation and regulation of p16, p21, p27 and c-myc

Oridonin Induces G2/M Cell Cycle Arrest and Apoptosis in Human Oral Squamous Cell Carcinoma.

Research and Development Progression of Oridonin for Hematological Malignancies Therapy

Oridonin Exerts Anticancer Effect on Osteosarcoma by Activating PPAR-γ and Inhibiting Nrf2 Pathway.

Galactosylated Chitosan Nanoparticles for Hepatocyte-Targeted Delivery of Oridonin

Oridonin Enhances the Radiosensitivity of Lung Cancer Cells by Upregulating Bax and Downregulating Bcl-2

Oridonin-loaded poly(ε-caprolactone)–poly(ethylene oxide)–poly(ε-caprolactone) copolymer nanoparticles: Preparation, characterization, and antitumor activity on mice with transplanted hepatoma

Oridonin triggers apoptosis in colorectal carcinoma cells and suppression of microRNA-32 expression augments oridonin-mediated apoptotic effects